This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Training and Resources

LYNPARZA™ (olaparib) in Ovarian Cancer

 

More information about LYNPARZA™ (olaparib):

Supporting documentation

100 mg and 150 mg film coated tablets
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

50 mg hard capsules
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-17803 | Date of Preparation: August 2019